To explore the impact of NUPR1+ macrophages on immunotherapy outcomes, tumor tissues were collected from patients with HCC undergoing PD‐1 blockade at Zhongshan Hospital, affiliated to Fudan University (Figure7A). This evidence concerns the gene NUPR1 and neoplasm.